** Analysts at Macquarie Group lift price target of New Zealand's Infratil IFT.NZ to NZ$12.91 from NZ$12.47; maintains "outperform" rating
** Macquarie attributes half of PT raise to guided densification at CDC's Marsden Park campus and increase in contracted FY27 capacity to 95% from 85%
** The remaining increase in PT largely reflects analysts' lower implied valuation discount for Infratil's U.S. based renewable energy platform Longroad Energy, driven by signals that more of its projects secured eligibility for federal tax incentives - Macquarie
** CDC confirmed on Wednesday it secured ~100 MW of new contracted capacity
** Global infra investment firm rises as much as 2.5% to NZ$12.70, its highest since September 12
** IFT, YTD up 0.3%
(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))